The Latest

COUR Pharmaceuticals Announces Biotechnology Industry Veteran Robert F. Carey Joins Board of Directors as Lead Independent Director

Skip to primary navigation
Skip to main content
Skip to footer

COUR Pharmaceuticals

Our Company
Our Technology
Our Clinical Trials
Publications & Media
- Press Releases
- Publications
Careers

Active Clinical Trials

CNP-201 Clinical Trial Peanut Allergy

CNP-104 Clinical Trial Primary Biliary Cholangitis

Our Clinical Trials -left image

Our Clinical Trials -right image

Footer

Our Company
Our Technology
Our Partners
Press
Careers

©

2023

COUR Pharmaceuticals.
All Rights Reserved.

Privacy Policy • Terms of Use